{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:31:30Z","timestamp":1780525890044,"version":"3.54.1"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32371000"],"award-info":[{"award-number":["32371000"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Independent Research Initiative of Yunnan Vaccine Laboratory","award":["YNVL2025ZY010"],"award-info":[{"award-number":["YNVL2025ZY010"]}]},{"name":"Independent Research Initiative of Yunnan Vaccine Laboratory","award":["YNVL2025ZY011"],"award-info":[{"award-number":["YNVL2025ZY011"]}]},{"name":"National Key Research and Development Program of China","award":["2023YFC2307600"],"award-info":[{"award-number":["2023YFC2307600"]}]},{"name":"The High-level Talent Promotion and Training Project of Kunming","award":["2022SCP001"],"award-info":[{"award-number":["2022SCP001"]}]},{"name":"R&D Program of Guangzhou National Laboratory","award":["GZNL2024A01001"],"award-info":[{"award-number":["GZNL2024A01001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-026-01386-z","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T21:33:57Z","timestamp":1769808837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Refined phenotyping of vaccine responses reveals transcriptomic determinants of neutralizing antibody heterogeneity"],"prefix":"10.1038","volume":"11","author":[{"given":"Qingqin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuyu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xupu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijie Scott","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"1386_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-698X-9-S1-S2","volume":"9","author":"P Duclos","year":"2009","unstructured":"Duclos, P., Okwo-Bele, J.-M., Gacic-Dobo, M. & Cherian, T. Global immunization: status, progress, challenges and future. BMC International Health and Human Rights 9, S2 (2009).","journal-title":"BMC International Health and Human Rights"},{"key":"1386_CR2","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1073\/pnas.1704507114","volume":"114","author":"WA Orenstein","year":"2017","unstructured":"Orenstein, W. A. & Ahmed, R. Simply put: Vaccination saves lives. Proc Natl Acad Sci USA 114, 4031\u20134033 (2017).","journal-title":"Proc Natl Acad Sci USA"},{"key":"1386_CR3","doi-asserted-by":"publisher","first-page":"20130433","DOI":"10.1098\/rstb.2013.0433","volume":"369","author":"B Greenwood","year":"2014","unstructured":"Greenwood, B. The contribution of vaccination to global health: past, present and future. Philos Trans R Soc Lond B Biol Sci 369, 20130433 (2014).","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"1386_CR4","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1016\/j.vaccine.2017.07.062","volume":"36","author":"GA Poland","year":"2018","unstructured":"Poland, G. A., Ovsyannikova, I. G. & Kennedy, R. B. Personalized vaccinology: A review. Vaccine 36, 5350\u20135357 (2018).","journal-title":"Vaccine"},{"key":"1386_CR5","doi-asserted-by":"publisher","unstructured":"Zimmermann, P. & Curtis, N. Factors That Influence the Immune Response to Vaccination. Clin. Microbiol. Rev. 32, https:\/\/doi.org\/10.1128\/cmr.00084-18 (2019).","DOI":"10.1128\/cmr.00084-18"},{"key":"1386_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/1389202916666141223220551","volume":"16","author":"J Castiblanco","year":"2015","unstructured":"Castiblanco, J. & Anaya, J. M. Genetics and vaccines in the era of personalized medicine. Curr Genomics 16, 47\u201359 (2015).","journal-title":"Curr Genomics"},{"key":"1386_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cell.2014.03.031","volume":"157","author":"JS Tsang","year":"2014","unstructured":"Tsang, J. S. et al. Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell 157, 499\u2013513 (2014).","journal-title":"Cell"},{"key":"1386_CR8","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.it.2015.06.005","volume":"36","author":"JS Tsang","year":"2015","unstructured":"Tsang, J. S. Utilizing population variation, vaccination, and systems biology to study human immunology. Trends Immunol 36, 479\u2013493 (2015).","journal-title":"Trends Immunol"},{"key":"1386_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/gene.2013.14","volume":"14","author":"RB Kennedy","year":"2013","unstructured":"Kennedy, R. B. et al. Transcriptomic profiles of high and low antibody responders to smallpox vaccine. Genes Immun 14, 277\u2013285 (2013).","journal-title":"Genes Immun"},{"key":"1386_CR10","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3389\/fimmu.2021.713351","volume":"12","author":"N K\u00f6rber","year":"2021","unstructured":"K\u00f6rber, N. et al. Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24highCD38high Regulatory B Cells and Lower Levels of IL-10 Expression Compared to Responders. Frontiers in Immunology 12, 2021 (2021).","journal-title":"Frontiers in Immunology"},{"key":"1386_CR11","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1016\/j.celrep.2017.08.023","volume":"20","author":"A Rechtien","year":"2017","unstructured":"Rechtien, A. et al. Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV. Cell Reports 20, 2251\u20132261 (2017).","journal-title":"Cell Reports"},{"key":"1386_CR12","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/ni.2067","volume":"12","author":"HI Nakaya","year":"2011","unstructured":"Nakaya, H. I. et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 12, 786\u2013795 (2011).","journal-title":"Nat Immunol"},{"key":"1386_CR13","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/s41590-022-01329-5","volume":"23","author":"S Fourati","year":"2022","unstructured":"Fourati, S. et al. Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination. Nature Immunology 23, 1777\u20131787 (2022).","journal-title":"Nature Immunology"},{"key":"1386_CR14","doi-asserted-by":"publisher","first-page":"103805","DOI":"10.1016\/j.ebiom.2021.103805","volume":"75","author":"G Moncunill","year":"2022","unstructured":"Moncunill, G. et al. Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and na\u00efve healthcare workers. eBioMedicine 75, 103805 (2022).","journal-title":"eBioMedicine"},{"key":"1386_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59259-1","volume":"14","author":"CB Santos-Rebou\u00e7as","year":"2024","unstructured":"Santos-Rebou\u00e7as, C. B. et al. Immune response stability to the SARS-CoV-2 mRNA vaccine booster is influenced by differential splicing of HLA genes. Scientific Reports 14, 8982 (2024).","journal-title":"Scientific Reports"},{"key":"1386_CR16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1080\/22221751.2022.2030197","volume":"11","author":"K Lin","year":"2022","unstructured":"Lin, K. et al. B cell receptor signatures associated with strong and poor SARS-CoV-2 vaccine responses. Emerg Microbes Infect 11, 452\u2013464 (2022).","journal-title":"Emerg Microbes Infect"},{"key":"1386_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/infdis\/jiac421","volume":"227","author":"M Agallou","year":"2023","unstructured":"Agallou, M. et al. Antibody and T-Cell Subsets Analysis Unveils an Immune Profile Heterogeneity Mediating Long-term Responses in Individuals Vaccinated Against SARS-CoV-2. J Infect Dis 227, 353\u2013363 (2023).","journal-title":"J Infect Dis"},{"key":"1386_CR18","doi-asserted-by":"publisher","first-page":"nwac066","DOI":"10.1093\/nsr\/nwac066","volume":"9","author":"T Zhou","year":"2022","unstructured":"Zhou, T. et al. A third dose of inactivated SARS-CoV-2 vaccine induces robust antibody responses in people with inadequate response to two-dose vaccination. Natl Sci Rev 9, nwac066 (2022).","journal-title":"Natl Sci Rev"},{"key":"1386_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.hlife.2024.01.005","volume":"2","author":"X Yu","year":"2024","unstructured":"Yu, X. et al. Safety, immunogenicity, and preliminary efficacy of a randomized clinical trial of omicron XBB.1.5-containing bivalent mRNA vaccine. hLife 2, 113\u2013125 (2024).","journal-title":"hLife"},{"key":"1386_CR20","doi-asserted-by":"publisher","unstructured":"Wang, Y. et al. Mucosal adenovirus vaccine Ad5-XBB.1.5 boosting elicits nasal IgA and transiently prevents JN.1 wave infection for less than 6 months in real-world settings. hLife, https:\/\/doi.org\/10.1016\/j.hlife.2025.05.001 (2025).","DOI":"10.1016\/j.hlife.2025.05.001"},{"key":"1386_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.hlife.2024.03.001","volume":"2","author":"L Gao","year":"2024","unstructured":"Gao, L. et al. Safety and immunogenicity of COVID-19 vaccine ZF2001 in Chinese aged 60 years and older. hLife 2, 257\u2013261 (2024).","journal-title":"hLife"},{"key":"1386_CR22","doi-asserted-by":"publisher","unstructured":"Papadopoli, R. et al. Serological Response to SARS-CoV-2 Messenger RNA Vaccine: Real-World Evidence from Italian Adult Population. Vaccines (Basel) 9, https:\/\/doi.org\/10.3390\/vaccines9121494 (2021).","DOI":"10.3390\/vaccines9121494"},{"key":"1386_CR23","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.vaccine.2022.02.045","volume":"40","author":"T Kageyama","year":"2022","unstructured":"Kageyama, T. et al. Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2. Vaccine 40, 2129\u20132133 (2022).","journal-title":"Vaccine"},{"key":"1386_CR24","doi-asserted-by":"publisher","first-page":"eadq7006","DOI":"10.1126\/sciadv.adq7006","volume":"10","author":"S Kumar","year":"2024","unstructured":"Kumar, S. et al. Systemic dysregulation and molecular insights into poor influenza vaccine response in the aging population. Science Advances 10, eadq7006 (2024).","journal-title":"Science Advances"},{"key":"1386_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1508659","volume":"16","author":"S Lucchesi","year":"2025","unstructured":"Lucchesi, S. et al. Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patients. Front Immunol 16, 1508659 (2025).","journal-title":"Front Immunol"},{"key":"1386_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1056\/NEJMc2032195","volume":"384","author":"AT Widge","year":"2021","unstructured":"Widge, A. T. et al. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination. N Engl J Med 384, 80\u201382 (2021).","journal-title":"N Engl J Med"},{"key":"1386_CR27","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1056\/NEJMoa2114583","volume":"385","author":"EG Levin","year":"2021","unstructured":"Levin, E. G. et al. Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months. New England Journal of Medicine 385, e84 (2021).","journal-title":"New England Journal of Medicine"},{"key":"1386_CR28","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1016\/S2666-5247(21)00025-2","volume":"2","author":"WN Chia","year":"2021","unstructured":"Chia, W. N. et al. Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study. The Lancet Microbe 2, e240\u2013e249 (2021).","journal-title":"The Lancet Microbe"},{"key":"1386_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jinf.2022.08.041","volume":"86","author":"T Shi","year":"2023","unstructured":"Shi, T. et al. Dynamics of immune responses to inactivated COVID-19 vaccination over 8 months in China. Journal of Infection 86, 66\u2013117 (2023).","journal-title":"Journal of Infection"},{"key":"1386_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100793","volume":"3","author":"JME Lim","year":"2022","unstructured":"Lim, J. M. E. et al. A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines. Cell Rep Med 3, 100793. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100793 (2022).","journal-title":"Cell Rep Med"},{"key":"1386_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran, D., Hu, Z. & Butte, A. J. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biology 18, 220 (2017).","journal-title":"Genome Biology"},{"key":"1386_CR32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41592-021-01142-2","volume":"18","author":"L Song","year":"2021","unstructured":"Song, L. et al. TRUST4: immune repertoire reconstruction from bulk and single-cell RNA-seq data. Nature Methods 18, 627\u2013630 (2021).","journal-title":"Nature Methods"},{"key":"1386_CR33","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ygeno.2020.12.036","volume":"113","author":"P Wang","year":"2021","unstructured":"Wang, P. et al. Comprehensive analysis of TCR repertoire in COVID-19 using single cell sequencing. Genomics 113, 456\u2013462 (2021).","journal-title":"Genomics"},{"key":"1386_CR34","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1128\/MCB.01466-10","volume":"31","author":"B Del Valle-P\u00e9rez","year":"2011","unstructured":"Del Valle-P\u00e9rez, B., Arqu\u00e9s, O., Vinyoles, M., de Herreros, A. G. & Du\u00f1ach, M. Coordinated action of CK1 isoforms in canonical Wnt signaling. Mol Cell Biol 31, 2877\u20132888 (2011).","journal-title":"Mol Cell Biol"},{"key":"1386_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-231","volume":"13","author":"B Schittek","year":"2014","unstructured":"Schittek, B. & Sinnberg, T. Biological functions of casein kinase 1 isoforms and putative roles in tumorigenesis. Mol Cancer 13, 231 (2014).","journal-title":"Mol Cancer"},{"key":"1386_CR36","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1091\/mbc.e04-06-0463","volume":"16","author":"J Zhang","year":"2005","unstructured":"Zhang, J. et al. Cdc42 and RhoB activation are required for mannose receptor-mediated phagocytosis by human alveolar macrophages. Mol Biol Cell 16, 824\u2013834 (2005).","journal-title":"Mol Biol Cell"},{"key":"1386_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s13105-012-0201-z","volume":"69","author":"XH Wang","year":"2013","unstructured":"Wang, X. H., Wang, Y., Diao, F. & Lu, J. RhoB is involved in lipopolysaccharide-induced inflammation in mouse in vivo and in vitro. Journal of Physiology and Biochemistry 69, 189\u2013197 (2013).","journal-title":"Journal of Physiology and Biochemistry"},{"key":"1386_CR38","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1016\/j.yexcr.2007.07.014","volume":"313","author":"AP Wheeler","year":"2007","unstructured":"Wheeler, A. P. & Ridley, A. J. RhoB affects macrophage adhesion, integrin expression and migration. Experimental Cell Research 313, 3505\u20133516 (2007).","journal-title":"Experimental Cell Research"},{"key":"1386_CR39","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1056\/NEJMc2103916","volume":"384","author":"N Doria-Rose","year":"2021","unstructured":"Doria-Rose, N. et al. Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19. N Engl J Med 384, 2259\u20132261 (2021).","journal-title":"N Engl J Med"},{"key":"1386_CR40","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","volume":"27","author":"DS Khoury","year":"2021","unstructured":"Khoury, D. S. et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nature Medicine 27, 1205\u20131211 (2021).","journal-title":"Nature Medicine"},{"key":"1386_CR41","doi-asserted-by":"publisher","unstructured":"Jiang, W. et al. Re-Evaluation and Retrospective Comparison of Serum Neutralization Induced by Three Different Types of Inactivated SARS-CoV-2 Vaccines. Vaccines (Basel) 12, https:\/\/doi.org\/10.3390\/vaccines12111204 (2024).","DOI":"10.3390\/vaccines12111204"},{"key":"1386_CR42","doi-asserted-by":"publisher","unstructured":"Rogliani, P., Chetta, A., Cazzola, M. & Calzetta, L. SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines. Vaccines (Basel) 9, https:\/\/doi.org\/10.3390\/vaccines9030227 (2021).","DOI":"10.3390\/vaccines9030227"},{"key":"1386_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106315","volume":"89","author":"X Chen","year":"2024","unstructured":"Chen, X. et al. Assessment of neutralizing antibody response as a correlate of protection against symptomatic SARS-CoV-2 infections after administration of two doses of the CoronaVac inactivated COVID-19 vaccine: A phase III randomized controlled trial. J Infect 89, 106315 (2024).","journal-title":"J Infect"},{"key":"1386_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s43856-022-00151-2","volume":"2","author":"DF Lake","year":"2022","unstructured":"Lake, D. F. et al. Third COVID-19 vaccine dose boosts neutralizing antibodies in poor responders. Commun Med (Lond) 2, 85 (2022).","journal-title":"Commun Med (Lond)"},{"key":"1386_CR45","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu, T., Zhang, L., Joo, D. & Sun, S.-C. NF-\u03baB signaling in inflammation. Signal Transduction and Targeted Therapy 2, 17023 (2017).","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"1386_CR46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1084\/jem.20040733","volume":"201","author":"MY Kimura","year":"2005","unstructured":"Kimura, M. Y. et al. Regulation of T helper type 2 cell differentiation by murine Schnurri-2. J Exp Med 201, 397\u2013408 (2005).","journal-title":"J Exp Med"},{"key":"1386_CR47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cellimm.2015.10.006","volume":"299","author":"CJ Johnston","year":"2016","unstructured":"Johnston, C. J., Smyth, D. J., Dresser, D. W. & Maizels, R. M. TGF-\u03b2 in tolerance, development and regulation of immunity. Cell Immunol 299, 14\u201322 (2016).","journal-title":"Cell Immunol"},{"key":"1386_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.immuni.2015.06.010","volume":"43","author":"I Kashiwagi","year":"2015","unstructured":"Kashiwagi, I. et al. Smad2 and Smad3 Inversely Regulate TGF-\u03b2 Autoinduction in Clostridium butyricum-Activated Dendritic Cells. Immunity 43, 65\u201379 (2015).","journal-title":"Immunity"},{"key":"1386_CR49","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1172\/JCI68552","volume":"123","author":"Y Lu","year":"2013","unstructured":"Lu, Y. et al. Kruppel-like factor 15 is critical for vascular inflammation. J Clin Invest 123, 4232\u20134241 (2013).","journal-title":"J Clin Invest"},{"key":"1386_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2017.12.012","volume":"48","author":"C Guti\u00e9rrez-V\u00e1zquez","year":"2018","unstructured":"Guti\u00e9rrez-V\u00e1zquez, C. & Quintana, F. J. Regulation of the Immune Response by the Aryl Hydrocarbon Receptor. Immunity 48, 19\u201333 (2018).","journal-title":"Immunity"},{"key":"1386_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115798","volume":"216","author":"CA Opitz","year":"2023","unstructured":"Opitz, C. A., Holfelder, P., Prentzell, M. T. & Trump, S. The complex biology of aryl hydrocarbon receptor activation in cancer and beyond. Biochemical Pharmacology 216, 115798 (2023).","journal-title":"Biochemical Pharmacology"},{"key":"1386_CR52","doi-asserted-by":"publisher","first-page":"19512","DOI":"10.1074\/jbc.M309074200","volume":"279","author":"JY Cho","year":"2004","unstructured":"Cho, J. Y. et al. Isoforms of the Ets transcription factor NERF\/ELF-2 physically interact with AML1 and mediate opposing effects on AML1-mediated transcription of the B cell-specific blk gene. J Biol Chem 279, 19512\u201319522 (2004).","journal-title":"J Biol Chem"},{"key":"1386_CR53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13045-017-0446-7","volume":"10","author":"FHX Guan","year":"2017","unstructured":"Guan, F. H. X. et al. The antiproliferative ELF2 isoform, ELF2B, induces apoptosis in vitro and perturbs early lymphocytic development in vivo. Journal of Hematology & Oncology 10, 75 (2017).","journal-title":"Journal of Hematology & Oncology"},{"key":"1386_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.803742","volume":"12","author":"E Schulz","year":"2021","unstructured":"Schulz, E. et al. CD19+IgD+CD27- Na\u00efve B Cells as Predictors of Humoral Response to COVID 19 mRNA Vaccination in Immunocompromised Patients. Front Immunol 12, 803742 (2021).","journal-title":"Front Immunol"},{"key":"1386_CR55","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3389\/fimmu.2019.01529","volume":"10","author":"DY Tesfaye","year":"2019","unstructured":"Tesfaye, D. Y., Gudjonsson, A., Bogen, B. & Fossum, E. Targeting Conventional Dendritic Cells to Fine-Tune Antibody Responses. Front Immunol 10, 1529 (2019).","journal-title":"Front Immunol"},{"key":"1386_CR56","doi-asserted-by":"publisher","unstructured":"Liu, X. et al. The Promotion of Humoral Immune Responses in Humans via SOCS1-Mediated Th2-Bias Following SARS-CoV-2 Vaccination. Vaccines (Basel) 11, https:\/\/doi.org\/10.3390\/vaccines11111730 (2023).","DOI":"10.3390\/vaccines11111730"},{"key":"1386_CR57","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01685-24","volume":"99","author":"P Samaan","year":"2025","unstructured":"Samaan, P. et al. mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-\u03b3 and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity. J Virol 99, e0168524 (2025).","journal-title":"J Virol"},{"key":"1386_CR58","first-page":"32","volume":"1","author":"K Natarajan","year":"1999","unstructured":"Natarajan, K., Li, H., Mariuzza, R. A. & Margulies, D. H. MHC class I molecules, structure and function. Rev Immunogenet 1, 32\u201346 (1999).","journal-title":"Rev Immunogenet"},{"key":"1386_CR59","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3389\/fimmu.2019.00964","volume":"10","author":"A Lin","year":"2019","unstructured":"Lin, A. & Yan, W. H. The Emerging Roles of Human Leukocyte Antigen-F in Immune Modulation and Viral Infection. Front Immunol 10, 964 (2019).","journal-title":"Front Immunol"},{"key":"1386_CR60","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.3389\/fimmu.2019.02986","volume":"10","author":"F Jordier","year":"2019","unstructured":"Jordier, F. et al. HLA-H: Transcriptional Activity and HLA-E Mobilization. Front Immunol 10, 2986 (2019).","journal-title":"Front Immunol"},{"key":"1386_CR61","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/iji.12443","volume":"46","author":"BS Carey","year":"2019","unstructured":"Carey, B. S., Poulton, K. V. & Poles, A. Factors affecting HLA expression: A review. Int J Immunogenet 46, 307\u2013320 (2019).","journal-title":"Int J Immunogenet"},{"key":"1386_CR62","doi-asserted-by":"publisher","first-page":"e1006338","DOI":"10.1371\/journal.pgen.1006338","volume":"12","author":"AA Pai","year":"2016","unstructured":"Pai, A. A. et al. Widespread Shortening of 3\u2019 Untranslated Regions and Increased Exon Inclusion Are Evolutionarily Conserved Features of Innate Immune Responses to Infection. PLoS Genet 12, e1006338 (2016).","journal-title":"PLoS Genet"},{"key":"1386_CR63","doi-asserted-by":"publisher","first-page":"e1012061","DOI":"10.1371\/journal.ppat.1012061","volume":"20","author":"Y Ge","year":"2024","unstructured":"Ge, Y. et al. Downregulation of CPSF6 leads to global mRNA 3\u2019 UTR shortening and enhanced antiviral immune responses. PLoS Pathog 20, e1012061 (2024).","journal-title":"PLoS Pathog"},{"key":"1386_CR64","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ni921","volume":"4","author":"KA Fitzgerald","year":"2003","unstructured":"Fitzgerald, K. A. et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4, 491\u2013496 (2003).","journal-title":"Nat Immunol"},{"key":"1386_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04486-9","volume":"21","author":"Y Liu","year":"2023","unstructured":"Liu, Y., Xie, B. & Chen, Q. RAS signaling and immune cells: a sinister crosstalk in the tumor microenvironment. J Transl Med 21, 595 (2023).","journal-title":"J Transl Med"},{"key":"1386_CR66","volume":"4","author":"J Yin","year":"2023","unstructured":"Yin, J. et al. Immune response and homeostasis mechanism following administration of BBIBP-CorV SARS-CoV-2 inactivated vaccine. Innovation (Camb) 4, 100359 (2023).","journal-title":"Innovation (Camb)"},{"key":"1386_CR67","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41392-021-00753-7","volume":"6","author":"X-N Zhao","year":"2021","unstructured":"Zhao, X.-N. et al. Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients. Signal Transduction and Targeted Therapy 6, 342 (2021).","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"1386_CR68","doi-asserted-by":"publisher","unstructured":"Rao, V. et al. Convergent and clonotype-enriched mutations in the light chain drive affinity maturation of a public antibody. bioRxiv, https:\/\/doi.org\/10.1101\/2025.03.07.642041 (2025).","DOI":"10.1101\/2025.03.07.642041"},{"key":"1386_CR69","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.humimm.2021.10.007","volume":"83","author":"H Xiang","year":"2022","unstructured":"Xiang, H. et al. Landscapes and dynamic diversifications of B-cell receptor repertoires in COVID-19 patients. Hum Immunol 83, 119\u2013129 (2022).","journal-title":"Hum Immunol"},{"key":"1386_CR70","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1126\/science.abd2321","volume":"369","author":"M Yuan","year":"2020","unstructured":"Yuan, M. et al. Structural basis of a shared antibody response to SARS-CoV-2. Science 369, 1119\u20131123 (2020).","journal-title":"Science"},{"key":"1386_CR71","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/s41564-022-01235-4","volume":"7","author":"P He","year":"2022","unstructured":"He, P. et al. SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope. Nature Microbiology 7, 1635\u20131649 (2022).","journal-title":"Nature Microbiology"},{"key":"1386_CR72","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","volume":"584","author":"DF Robbiani","year":"2020","unstructured":"Robbiani, D. F. et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature 584, 437\u2013442 (2020).","journal-title":"Nature"},{"key":"1386_CR73","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.2147\/RMHP.S336039","volume":"14","author":"Y Wu","year":"2021","unstructured":"Wu, Y., Zhang, Q., Li, L., Li, M. & Zuo, Y. Control and Prevention of the COVID-19 Epidemic in China: A Qualitative Community Case Study. Risk Manag Healthc Policy 14, 4907\u20134922 (2021).","journal-title":"Risk Manag Healthc Policy"},{"key":"1386_CR74","first-page":"2022","volume":"13","author":"F Wang","year":"2022","unstructured":"Wang, F. et al. Factors associated with neutralizing antibody levels induced by two inactivated COVID-19 vaccines for 12 months after primary series vaccination. Frontiers in Immunology 13, 2022 (2022).","journal-title":"Frontiers in Immunology"},{"key":"1386_CR75","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41374-021-00663-w","volume":"102","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y., Zhang, L., Xie, Y.-H. & Wu, J. Advancements in detection of SARS-CoV-2 infection for confronting COVID-19 pandemics. Laboratory Investigation 102, 4\u201313 (2022).","journal-title":"Laboratory Investigation"},{"key":"1386_CR76","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0140-6736(21)01429-X","volume":"398","author":"MD Tanriover","year":"2021","unstructured":"Tanriover, M. D. et al. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. Lancet 398, 213\u2013222 (2021).","journal-title":"Lancet"},{"key":"1386_CR77","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S1473-3099(21)00462-X","volume":"22","author":"S Xia","year":"2022","unstructured":"Xia, S. et al. Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1\/2 trial. Lancet Infect Dis 22, 196\u2013208 (2022).","journal-title":"Lancet Infect Dis"},{"key":"1386_CR78","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/S1473-3099(21)00319-4","volume":"21","author":"B Han","year":"2021","unstructured":"Han, B. et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1\/2 clinical trial. Lancet Infect Dis 21, 1645\u20131653 (2021).","journal-title":"Lancet Infect Dis"},{"key":"1386_CR79","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1467-985X.2010.00676_9.x","volume":"174","author":"C Ginestet","year":"2011","unstructured":"Ginestet, C. ggplot2: Elegant Graphics for Data Analysis. Journal of the Royal Statistical Society Series A: Statistics in Society 174, 245\u2013246 (2011).","journal-title":"Journal of the Royal Statistical Society Series A: Statistics in Society"},{"key":"1386_CR80","unstructured":"M\u00e4chler, M., Rousseeuw, P., Struyf, A., Hubert, M. & Hornik, K. Cluster: Cluster Analysis Basics and Extensions. Vol. 1 (2012)."},{"key":"1386_CR81","doi-asserted-by":"publisher","unstructured":"Martin, M. CUTADAPT removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17, https:\/\/doi.org\/10.14806\/ej.17.1.200 (2011).","DOI":"10.14806\/ej.17.1.200"},{"key":"1386_CR82","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884\u2013i890 (2018).","journal-title":"Bioinformatics"},{"key":"1386_CR83","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2012","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2012).","journal-title":"Bioinformatics"},{"key":"1386_CR84","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gr.209601.116","volume":"27","author":"T Smith","year":"2017","unstructured":"Smith, T., Heger, A. & Sudbery, I. UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy. Genome Res 27, 491\u2013499 (2017).","journal-title":"Genome Res"},{"key":"1386_CR85","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/bioinformatics\/btr174","volume":"27","author":"DW Barnett","year":"2011","unstructured":"Barnett, D. W., Garrison, E. K., Quinlan, A. R., Str\u00f6mberg, M. P. & Marth, G. T. BamTools: a C++ API and toolkit for analyzing and managing BAM files. Bioinformatics 27, 1691\u20131692 (2011).","journal-title":"Bioinformatics"},{"key":"1386_CR86","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2013","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2013).","journal-title":"Bioinformatics"},{"key":"1386_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37266-6","volume":"14","author":"KC Cotto","year":"2023","unstructured":"Cotto, K. C. et al. Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer. Nature Communications 14, 1589 (2023).","journal-title":"Nature Communications"},{"key":"1386_CR88","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41588-017-0004-9","volume":"50","author":"YI Li","year":"2018","unstructured":"Li, Y. I. et al. Annotation-free quantification of RNA splicing using LeafCutter. Nature Genetics 50, 151\u2013158 (2018).","journal-title":"Nature Genetics"},{"key":"1386_CR89","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"1386_CR90","doi-asserted-by":"publisher","first-page":"D1027","DOI":"10.1093\/nar\/gkx892","volume":"46","author":"X Feng","year":"2017","unstructured":"Feng, X., Li, L., Wagner, E. J. & Li, W. TC3A: The Cancer 3\u2032 UTR Atlas. Nucleic Acids Research 46, D1027\u2013D1030 (2017).","journal-title":"Nucleic Acids Research"},{"key":"1386_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology 15, 550 (2014).","journal-title":"Genome Biology"},{"key":"1386_CR92","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L.-G., Han, Y. & He, Q.-Y. clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters. OMICS: A Journal of Integrative Biology 16, 284\u2013287 (2012).","journal-title":"OMICS: A Journal of Integrative Biology"},{"key":"1386_CR93","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. bioRxiv, 060012, https:\/\/doi.org\/10.1101\/060012 (2021).","DOI":"10.1101\/060012"},{"key":"1386_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14, 7 (2013).","journal-title":"BMC Bioinformatics"},{"key":"1386_CR95","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nature Methods 12, 453\u2013457 (2015).","journal-title":"Nature Methods"},{"key":"1386_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v034.i02","volume":"34","author":"F Cribari-Neto","year":"2010","unstructured":"Cribari-Neto, F. & Zeileis, A. Beta Regression in R. Journal of Statistical Software 34, 1\u201324 (2010).","journal-title":"Journal of Statistical Software"},{"key":"1386_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).","journal-title":"BMC Bioinformatics"},{"key":"1386_CR98","doi-asserted-by":"publisher","first-page":"e1000435","DOI":"10.1371\/journal.pbio.1000435","volume":"8","author":"S Aerts","year":"2010","unstructured":"Aerts, S. et al. Robust Target Gene Discovery through Transcriptome Perturbations and Genome-Wide Enhancer Predictions in Drosophila Uncovers a Regulatory Basis for Sensory Specification. PLOS Biology 8, e1000435 (2010).","journal-title":"PLOS Biology"},{"key":"1386_CR99","doi-asserted-by":"publisher","first-page":"e12776","DOI":"10.1371\/journal.pone.0012776","volume":"5","author":"VA Huynh-Thu","year":"2010","unstructured":"Huynh-Thu, V. A., Irrthum, A., Wehenkel, L. & Geurts, P. Inferring Regulatory Networks from Expression Data Using Tree-Based Methods. PLOS ONE 5, e12776 (2010).","journal-title":"PLOS ONE"},{"key":"1386_CR100","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/ng.3581","volume":"48","author":"B Li","year":"2016","unstructured":"Li, B. et al. Landscape of tumor-infiltrating T cell repertoire of human cancers. Nat Genet 48, 725\u2013732 (2016).","journal-title":"Nat Genet"},{"key":"1386_CR101","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1093\/bioinformatics\/btv359","volume":"31","author":"NT Gupta","year":"2015","unstructured":"Gupta, N. T. et al. Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data. Bioinformatics 31, 3356\u20133358 (2015).","journal-title":"Bioinformatics"},{"key":"1386_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v039.i05","volume":"39","author":"N Simon","year":"2011","unstructured":"Simon, N., Friedman, J., Hastie, T. & Tibshirani, R. Regularization Paths for Cox\u2019s Proportional Hazards Model via Coordinate Descent. J Stat Softw 39, 1\u201313 (2011).","journal-title":"J Stat Softw"},{"key":"1386_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12, 77 (2011).","journal-title":"BMC Bioinformatics"},{"key":"1386_CR104","doi-asserted-by":"publisher","unstructured":"Zhang, S. et al. The GSA Family in 2025: A Broadened Sharing Platform for Multi-Omics and Multimodal Data. Genomics Proteomics Bioinformatics, https:\/\/doi.org\/10.1093\/gpbjnl\/qzaf072 (2025).","DOI":"10.1093\/gpbjnl\/qzaf072"},{"key":"1386_CR105","unstructured":"Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2025. Nucleic Acids Res. 53, D30-d44, (2025)."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01386-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01386-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01386-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T14:03:38Z","timestamp":1772633018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01386-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1386"],"URL":"https:\/\/doi.org\/10.1038\/s41541-026-01386-z","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}